Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Next and Synthomer cut outlook; new M&G CEO

Thu, 29th Sep 2022 07:49

(Alliance News) - The mood soured just before the European equities open on Thursday.

The Swedish Coast Guard found another leak in undersea gas pipelines running from Russia to Europe.

Stocks had initially been called higher on Thursday, with the Bank of England's bond market intervention lifting the mood.

The Nord Stream news put paid to hopes for a positive open in Europe, however.

"There are two leaks on the Swedish side and two leaks on the Danish side," a Swedish Coast Guard official said, after three leaks were confirmed earlier this week on the Nord Stream pipelines in the Baltic Sea.

Meanwhile, UK retailer Next lowered its guidance for annual sales and profit.

Here is what you need to know ahead of the London market open:

----------

MARKETS

----------

FTSE 100: called down 0.3% at 6,982.29

----------

Hang Seng: down 0.8% at 17,105.61

Nikkei 225: closed up 1.0% at 26,422.05

S&P/ASX 200: closed up 1.4%. at 6,555.00

----------

DJIA: closed up 548.75 points, or 1.9%, at 29,683.74

S&P 500: closed up 71.75 points, or 2.0%, at 3,719.04

Nasdaq Composite: closed up 222.13 points, or 2.1%, at 11,051.64

----------

EUR: up at USD0.9660 (USD0.9645)

GBP: firm at USD1.0772 (USD1.0763)

USD: up at JPY144.68 (JPY144.41)

GOLD: lower at USD1,644.93 per ounce (USD1,653.20)

OIL (Brent): flat at USD88.23 a barrel (USD88.17)

(changes since previous London equities close)

----------

ECONOMICS

----------

Thursday's key economic events still to come:

1000 BST eurozone economic sentiment indicator

1300 BST Germany consumer price index

1330 BST US gross domestic product

1330 BST US initial jobless claims

----------

Kemi Badenoch has used her first overseas visit as UK trade secretary to defend the government's economic strategies as "going for growth in a big way". There has been controversy since Chancellor Kwasi Kwarteng last week announced his mini-budget, which included plans to cut taxes to the benefit of the most wealthy. Badenoch told investors at the fifth annual Atlantic Future Forum hosted on the HMS Queen Elizabeth, moored in New York, the strategies were necessary due to a "global growth slow-down". The former Tory leadership candidate outlined a number of the government's strategies to the forum, where UK businesses across the defence and technology sector aimed to attract US investors.

----------

The number of cars built in the UK has increased for the fourth month in a row, new figures show. A total of 49,901 cars were built in August, up 34% compared with a year ago, the Society of Motor Manufacturers & Traders said. But the figure was well below August 2019's pre-pandemic level of 92,158 units, which the SMMT said underlined the scale of recovery still needed in the industry. Production of battery electric, plug-in hybrid and hybrid vehicles increased. Almost a third of all cars made in Britain in August were one of these models, with most exported to global markets.

----------

Price sensitivity is showing signs of returning to the UK housing market as house hunters' buying power takes a hit, according to a property website. Zoopla said 6% of homes listed for sale have seen the asking price adjusted downwards by 5% or more, marking the highest level since before the coronavirus pandemic. The website said that, given the economic backdrop and factors including rising energy prices and rising interest rates, this is a clear sign of a return to more of a buyers' market, after two years of a market that favoured sellers. The findings were released in a week when a slew of mortgage products have been pulled from the market and rates have been hiked, amid turmoil after the mini-budget last Friday.

----------

BROKER RATING CHANGES

----------

Oddo BHF raises GSK to 'outperform' ('neutral') - price target 1,700 (1,540) pence

----------

RBC cuts THG to 'sector perform' ('outperform') - price target 50 (215) pence

----------

RBC cuts boohoo price target to 35 (65) pence - 'sector perform'

----------

Goldman Sachs cuts boohoo price target to 65 (115) pence - 'buy'

----------

COMPANIES - FTSE 100

----------

Next lowered annual guidance as the clothing and homewares retailer believes tough trading in August and cost-of-living pressures will offset any boost from recent UK government stimulus measures. In the half-year ended July 30, revenue climbed 12% to GBP2.38 billion from GBP2.12 billion a year earlier. Pretax profit advanced 16% year-on-year to GBP400.6 million from GBP346.7 million. Full price sales advanced 12% year-on-year in the first half, though the company now expects a decline for the second half. Full price sales are to shrink by 1.5% year-on-year. It had previously guided for 1% growth. Next also lowered bottom-line guidance. It now expects annual pretax profit of GBP840 million, down from the previous GBP860 million guidance, but up 2.1% on last year. "August trade was below our expectations and cost of living pressures are set to rise in the coming months. Sales in September have improved, and we may see benefits from recent government measures," Next said, adding that the decision to lower full price sales guidance was a "very difficult call". Next, returning to a normal dividend cycle, declared a 66 pence per share interim payout. It expects to declare a final dividend "no lower than" the 127p it paid in August.

----------

Holiday Inn-owner InterContinental Hotels said it is carrying out extra "recovery and assurance plans" after its technology systems were hit by "unauthorised activity" earlier this month. "Following a period of disruption, by Wednesday 7 September IHG had re-activated its booking websites and mobile app together with most of its other booking channels and revenue-generating systems. Subsequently, service at our reservation and customer care call centres has been recovered and all our systems restored," the company explained. During the disruption, its hotel sites were able to to take booking directly. "We have continued to carry out additional steps as part of our recovery and assurance plans to review and further enhance our security measures. External specialists were engaged to investigate the incident, and no evidence of unauthorised access to systems storing guest data has been identified," IHG added.

----------

M&G has named Andrea Rossi as its new chief executive, effective October 10. He succeeds John Foley who steps down after seven years in the post. Foley's retirement from the role was announced in April. The wealth manager at the time said Foley would remain in the role until a replacement was found. Rossi was formerly CEO of AXA Investment Managers and spent six years on the executive committee of parent AXA SA. "Most recently, Andrea has been a senior adviser to Boston Consulting Group. He will step down from this role following his appointment at M&G," M&G added.

----------

COMPANIES - FTSE 250

----------

Mitchells & Butlers said fourth-quarter sales topped pre-virus levels, despite the pub and bar owner facing extreme hot weather in the UK and rail strikes. In the quarter ended September 24, total sales rose 1.5% from three years earlier, before the onset of the pandemic. "Like-for-like sales improved in the fourth quarter, despite the ongoing impact of extreme heat as well as further rail strikes, both of which disrupted trade. Sales over the August bank holiday were encouraging, with like-for-like growth over the three-day weekend of over 6%, before returning to levels consistent with the quarter as a whole," the company said. For the full-year, sales were up 1.1% on pre-virus levels. Mitchells & Butlers welcome UK energy price cap measures but warned it expects its total energy and utility costs to have risen to GBP150 million for the full year, up from the pre-pandemic comparative of GBP80 million. "Even with the cap in place anticipate a further increase on that for FY 2023," it warned.

----------

Synthomer cut yearly guidance as the Essex-based chemicals maker grapples with tough market conditions. It now expects its 2022 earnings before interest, tax, depreciation and amortisation to be 10% to 15% below previous expectations. "Since August, macroeconomic conditions have deteriorated, leading to reduced demand in construction and coatings end markets. This has impacted trading in Synthomer's European business," the company warned.

----------

OTHER COMPANIES

----------

Attraqt backed a GBP63.2 million takeover offer. Technology company Crownpeak will pay 30p per share in the London-based provider of online search, merchandising and personalisation solutions for e-commerce. This represents a 70% premium to Attraqt's 17.50p closing price on Wednesday. The bid values Attraqt's equity at GBP63.2 million. Crownpeak has so far received acceptances representing 42% of Attraqt shareholders. Attraqt also reported interim results. In the first half of 2022, revenue climbed 9.4% annually to GBP12.2 million from GBP11.1 million. Its pretax loss, however, widened to GBP2.2 million from GBP1.8 million.

----------

Avon Protection said it has received a first delivery order from the US Army for a "next generation" helmet. The order is worth USD42.1 million. "Manufacturing ramp-up is progressing to plan after completing rigorous testing, with initial deliveries commencing in the first half of FY23 positioning Avon Protection as the leading helmet supplier to the US [Department of Defense]," the company said.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.